Deep Parikh, MD, sat down with Emily Kaiser Maharjan from Optometry Times to talk about his presentation at Collaborative Care Symposium on advanced treatments in neovascular retinal disease.

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

Ocugen's drug to treat retina diseases received a rare pediatric disease designation from U.S. regulators. The biotechnology said Tuesday that the Food and Drug Administration granted the designation ...

Improvement in DRIL (p=0.048), ELM/EZ (p=0.001) and COST (p=0.002) disruption after treatment was associated with greater improvement in VA at 12 months. Eyes with cystoid macular oedema (p=0.003, ...

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

It will grow to $2.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. ” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The ...

Thermofluids for Energy and Advanced Material Laboratory, Department of Mechanical and Industrial Engineering, Institute for Sustainable Energy, Faculty of Applied Science and Engineering, University ...

Hamza Mussa, lead optometrist at Specsavers Banbury, and patient, Emma Williams, on a referral for a retinal tear ...

Doctors need to follow the boy longer to determine how well the treatment is working. But so far the bespoke therapy appears to have at least partially reversed his condition, reducing his risk of ...

doctors.org.uk Aims Retinal detachment (RD) is one of the most common of ophthalmic emergencies in the UK. Our aim was to study trends over time and regional variation in rates of RD in England.

The Jaguars did not provide details of Corsaro’s actions. “His behavior did not meet the university’s values and standards regarding the treatment of student athletes,” the university said in a ...